Clinical trial
A Phase II Study of Tesetaxel in Subjects Previously Treated With Chemotherapy for Metastatic Transitional Cell Carcinoma of the Urothelium
NCT01215877 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Tesetaxel in Subjects Previously Treated With Chemotherapy for Metastatic Transitional Cell Carcinoma of the Urothelium
- Lead sponsor
- Genta Incorporated
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 33 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.